Learning Curve of Robotic Radical Prostatectomy

Learning Curve of Robotic Radical Prostatectomy

June 25, 2015 at 10:23 AM 0 comments

Muhammed Ersagun Arslan,1 *Abdullah Erdem Canda,2 Ali Fuat Atmaca,2 Mevlana Derya Balbay,3 Ziya Akbulut,2 Serkan Altinova,1 Ahmet Tunc Ozdemir4 1. Department of Urology, Ankara Ataturk Training and Research Hospital, Ankara, Turkey 2. Department of Urology, School of Medicine, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey 3.Read More

Outcomes of Robotic Radical Prostatectomy in High-risk Prostate Cancer Patients: Experience in 60 Patients with Oncological and Functional Outcomes

Outcomes of Robotic Radical Prostatectomy in High-risk Prostate Cancer Patients: Experience in 60 Patients with Oncological and Functional Outcomes

June 25, 2015 at 10:19 AM 0 comments

*Abdullah Erdem Canda,1 Ali Fuat Atmaca,1 Emre Urer,2 Özer Ural Çakıcı,2 Serkan Altinova,2 Ziya Akbulut,1 Mevlana Derya Balbay3 1. Department of Urology, School of Medicine, Yildirim Beyazit University, Ankara Ataturk Training and Research Hospital, Ankara, Turkey 2. Department of Urology, Ankara Ataturk Training and Research Hospital, Ankara, Turkey 3. DepartmentRead More

Percutaneous Nephrolithotomy and Complications: Our Experience with 3,003 Cases

Percutaneous Nephrolithotomy and Complications: Our Experience with 3,003 Cases

June 25, 2015 at 10:15 AM 0 comments

Ahmet Çamtosun, *Hüseyin Çelik, İbrahim Topcu, Cemal Taşdemir, Ramazan Altıntaş, Serhan Çimen, Ali Güneş Department of Urology, Medical Faculty, Inonu University, Malatya, Turkey *Correspondence to huseyin.celik@inonu.edu.tr Disclosure: The authors have declared no conflicts of interest. Accepted: 01.05.15 Citation: EMJ Urol. 2015;3[3]:60-62. Abstract We report the outcomes of 3,003 percutaneous nephrolithotomyRead More

Outcomes of Six Patients Who were Treated with Selective Embolisation Due to Arteriovenous Fistula Following Percutaneous Nephrolithotomy

Outcomes of Six Patients Who were Treated with Selective Embolisation Due to Arteriovenous Fistula Following Percutaneous Nephrolithotomy

June 25, 2015 at 10:12 AM 0 comments

Cemal Selcuk Isoglu, *Tufan Suelozgen, Mehmet Yoldas, Hakan Turk, Mustafa Karabicak, Batuhan Ergani, Yusuf Ozlem Ilbey Department of Urology, Tepecik Training and Research Hospital, Izmir, Turkey *Correspondence to tsuelozgen@hotmail.com Disclosure: The authors have declared no conflicts of interest. Accepted: 01.05.15 Citation: EMJ Urol. 2015;3[3]:63-66. Abstract Objective: Arteriovenous fistula (AVF) isRead More

Effectiveness of Flexible Ureteroscopy and Laser Lithotripsy in the Management of Urinary Calculi in Patients with Congenital Abnormalities of the Kidney and Ureter

Effectiveness of Flexible Ureteroscopy and Laser Lithotripsy in the Management of Urinary Calculi in Patients with Congenital Abnormalities of the Kidney and Ureter

June 25, 2015 at 10:09 AM 0 comments

*Erdal Alkan,1 Ali Sarıbacak,2 Ahmet Oguz Ozkanli,3 Oguz Acar,1 Mevlana Derya Balbay1 1. Department of Urology, Memorial Sisli Hospital, Istanbul, Turkey 2. Department of Urology, Konak Hospital, İzmit, Turkey 3. Department of Anesthesiology, Memorial Sisli Hospital, Istanbul, Turkey *Correspondence to eralkan@hotmail.com Disclosure: We confirm that the paper has not beenRead More

Percutaneous Nephrolithotomy for Paediatric Stone Disease

Percutaneous Nephrolithotomy for Paediatric Stone Disease

June 25, 2015 at 10:03 AM 0 comments

*Hüseyin Çelik, Ahmet Çamtosun, Ramazan Altıntaş, Cemal Taşdemir, İbrahim Topcu, Serhan Çimen, Ali Güneş Department of Urology, Medical Faculty, Inonu University, Malatya, Turkey *Correspondence to huseyin.celik@inonu.edu.tr Disclosure: The authors have declared no conflicts of interest. Accepted: 01.05.15 Citation: EMJ Urol. 2015;3[3]:73-76. Abstract We evaluated the outcomes and complications occurring followingRead More

A New Approach for the Patient with Erectile Dysfunction

A New Approach for the Patient with Erectile Dysfunction

May 12, 2015 at 11:10 AM 0 comments

This symposium took place on 21st March 2015 (18.00–19.30) as part of the Annual European Association of Urology (EAU) Congress in Madrid, Spain Chairperson: Ian Eardley1 Speakers: Hartmut Porst,2 Ignacio Moncada,3 Béatrice Cuzin,4 Ian Eardley1 1. St James’s University Hospital and Leeds General Infirmary, Leeds, UK 2. Private Institute forRead More

Navigating the mCRPC Landscape: Exploring Key Clinical Decision Points

Navigating the mCRPC Landscape: Exploring Key Clinical Decision Points

May 12, 2015 at 11:04 AM 0 comments

Summary of presentations from the Bayer-supported satellite symposium, held at the European Association of Urology (EAU) Congress, Madrid, Spain on 22nd March 2015 Chairperson: Fred Saad1 Speakers: Gero Kramer,2 Bertrand Tombal,3 Jürgen Gschwend4 1. University of Montreal, Montreal, Canada 2. Medical University of Vienna, Vienna, Austria 3. Cliniques universitaires Saint-Luc,Read More

Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management

Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management

May 12, 2015 at 10:58 AM 0 comments

Caroline Charles,1 *Jean de la Rosette,2 *Mark Emberton3 1. Scilink Medical Writing, Saint-Pierre-d’Irube, France 2. Department of Urology, AMC University Hospital, Amsterdam, the Netherlands 3. Interventional Oncology, Division of Surgery and Interventional Science,  University College Hospital, London, UK *Correspondence to j.j.delarosette@amc.uva.nl and mark.emberton@uclh.nhs.uk Disclosure: M. Emberton has provided consultancy servicesRead More

Chemotherapy and New Drugs in Prostate Cancer

Chemotherapy and New Drugs in Prostate Cancer

May 12, 2015 at 10:55 AM 0 comments

*Nicolas Mottet Department of Urology, University Hospital, Hôpital Nord, St Etienne, France *Correspondence to Nicolas.mottet@chu-st-etienne.fr Disclosure: N.M. has received grants or research support from Takeda/Millenium, Astellas, Pierre Fabre, Sanofi, and Pasteur; and honoraria or consultation fees from Takeda/Millenium, Jansen, Astellas, BMS, Bayer, IPSEN, Ferring, Novartis, Nuclétron, Pierre Fabre, Sanofi, andRead More